← All Investors
AGIOS PHARMACEUTICALS INC
AGIO
Holders
5
Combined Value
$31M
Combined Shares
939,218
Current Price
$33.08
52W High
$46.00
vs 52W High
−28.1%
Investor Activity
BUYSELLImplied priceClick a quarter to see who traded
Held By
| Investor | Value | % of Portfolio | Avg Buy Price | Gain | Last Activity | As of |
|---|---|---|---|---|---|---|
| Ken Griffin - Citadel Advisors | $26M | 0.00% | ~$29.45 | +12.3% | Sold Q1 2026 | Q1 2026 |
| Paul Tudor Jones - Tudor Investment | $2.4M | 0.00% | ~$27.22 | +21.5% | Sold Q1 2026 | Q1 2026 |
| Cliff Asness - AQR Capital | $1.2M | 0.00% | ~$35.33 | −6.4% | Bought Q1 2026 | Q1 2026 |
| Israel Englander - Millennium Management | $1.1M | 0.00% | ~$27.30 | +21.2% | Sold Q1 2026 | Q1 2026 |
| Steve Cohen - Point72 | $994K | 0.00% | ~$27.64 | +19.7% | Sold Q1 2026 | Q1 2026 |
Recent Activity
Ownership History
| Period | Holders | Total Shares | Δ Shares | Total Value | Implied Price |
|---|---|---|---|---|---|
| Q1 2026 | 5 | 939,218 | −59.7% | $31M | $33.83 |
| Q4 2025 | 5 | 2,328,106 | +47.5% | $63M | $27.22 |
| Q3 2025 | 5 | 1,578,318 | −34.8% | $63M | $40.09 |
| Q2 2025 | 4 | 2,420,209 | +21.1% | $80M | $33.26 |
| Q1 2025 | 4 | 1,998,800 | −20.8% | $58M | $29.29 |
| Q4 2024 | 5 | 2,523,250 | +100.1% | $82M | $32.86 |
| Q3 2024 | 5 | 1,260,936 | +35.0% | $56M | $44.43 |
| Q2 2024 | 4 | 934,103 | — | $40M | $43.12 |